DERMOSCRIBE SEBORRHEIC DERMATITIS (DERMOSCRIBE PTY LTD)


Welcome to the PulseAid listing for the DERMOSCRIBE SEBORRHEIC DERMATITIS drug offered from DERMOSCRIBE PTY LTD. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: DERMOSCRIBE PTY LTD
NON-PROPRIETARY NAME: SULFUR, SALICYLIC ACID, HYDROCORTISONE
SUBSTANCE NAME: SULFUR; SALICYLIC ACID; HYDROCORTISONE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: CREAM
MARKETING CATEGORY NAME: OTC MONOGRAPH NOT FINAL
START MARKETING DATE: 2015-03-23
END MARKETING DATE: 0000-00-00


DERMOSCRIBE SEBORRHEIC DERMATITIS HUMAN OTC DRUG Details:

Item DescriptionDERMOSCRIBE SEBORRHEIC DERMATITIS from DERMOSCRIBE PTY LTD
LABELER NAME: DERMOSCRIBE PTY LTD
DEA SCHEDULE:
ACTIVE STRENGTH: 3; 3; 1(g/100g; g/100g; g/100g)
START MARKETING DATE: 2015-03-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69683-202_bd427c73-c412-449e-9bd6-bd1326ad7f8e
PRODUCT NDC: 69683-202
APPLICATION NUMBER: part348

Other SULFUR; SALICYLIC ACID; HYDROCORTISONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
DERMOSCRIBE PTY LTDDERMOSCRIBE SEBORRHEIC DERMATITIS